M27 Effect of pirfenidone on breathlessness as measured by the ucsd-sobq score in patients with idiopathic pulmonary fibrosis (ipf) with moderate lung function impairment von Glassberg, MK, Wijsenbeek, M, Gilberg, F, Petzinger, U, Kirchgaessler, KU, Albera, C

Volltext

C38 UNDERSTANDING THERAPEUTICS IN IPF: Effect Of Pirfenidone On Breathlessness As Measured By The Ucsd-Sobq Score In Patients With Idiopathic Pulmonary Fibrosis (ipf) With Moderate... von Glassberg, M K, Wijsenbeek, M, Gilberg, F, Petzinger, U, Kirchgassler, K-U, Albera, C

Volltext

Deferring treatment with pirfenidone results in loss of lung function that is not recovered by later treatment initiation von Maher, T., Jouneau, S., Morrison, L., Lederer, D., Molina-Molina, M., Kirchgaessler, K-U, Gilberg, F., Axmann, J., Petzinger, U., Bendstrup, E.

Volltext

M28 Deferring treatment with pirfenidone results in loss of lung function that is not recovered by later treatment initiation von Maher, T, Jouneau, S, Morrison, L, Lederer, D, Molina-Molina, M, Kirchgaessler, K-U, Gilberg, F, Axmann, J, Petzinger, U, Bendstrup, E

Volltext

C101 IPF: CLINICAL STUDIES, THERAPEUTICS, AND MORE II: Time-To-Event Analysis Of Common Adverse Events With Pirfenidone In Patients With Ipf- A Pooled Analysis Of Three Phase Iii C... von Mason, W R, Nathan, S D, Zibrak, J D, Padilla, M L, Gilberg, F, Petzinger, U, Kirchgaessler, K, Lancaster, L H

Volltext

C38 UNDERSTANDING THERAPEUTICS IN IPF: Safety Of The Combined Use Of Pirfenidone And Nintedanib In Patients With Idiopathic Pulmonary Fibrosis (ipf): Results From An Interim Analys... von Flaherty, K R, Sussman, R, Pesci, A, Nunes, H, Acosta, O, Petzinger, U, Stauffer, J, Gilberg, F, Bengus, M, Lancaster, L H

Volltext

M31 Safety of combined pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis von Flaherty, KR, Fell, CD, Huggins, JT, Nunes, H, Sussman, R, Valenzuela, C, Petzinger, U, Stauffer, JL, Gilberg, F, Bengus, M, Wijsenbeek, M

Volltext

Pirfenidone treatment in individuals with idiopathic pulmonary fibrosis: Impact of timing of treatment initiation von Maher, TM, Lancaster, LH, Jouneau, S, Morrison, L, Lederer, DJ, Molina-Molina, M, Bendstrup, E, Kirchgaessler, K-U, Gilberg, F, Axmann, J, Petzinger, U, Noble, PW

Volltext

The Effect of Exercise Training in Improving Motor Performance and Corticomotor Excitability in People With Early Parkinson's Disease von Fisher, Beth E., PhD, Wu, Allan D., MD, Salem, George J., PhD, Song, Jooeun, MS, Lin, Chien-Ho (Janice), PhD, Yip, Jeanine, DPT, Cen, Steven, PhD, Gordon, James, EdD, Jakowec, Michael, PhD, Petzinger, Giselle, MD

Volltext

Transport of taurocholate by mutants of negatively charged amino acids, cysteines, and threonines of the rat liver sodium‐dependent taurocholate cotransporting polypeptide Ntcp von Zahner, Daniel, Eckhardt, Uta, Petzinger, Ernst

Volltext

Differential cell sensitivity between OTA and LPS upon releasing TNF-α von Al-Anati, Lauy, Essid, Ebtisam, Stenius, Ulla, Beuerlein, Knut, Schuh, Klaus, Petzinger, Ernst

Volltext

Potential relation between mercury concentrations and necropsy findings in cetaceans from German waters of the North and Baltic seas von SIEBERT, U, JOIRIS, C, HOLSBEEK, L, BENKE, H, FAILING, K, FRESE, K, PETZINGER, E

Volltext

PieVis: Interactive Graph Visualization Using a Rings-Based Tree Drawing Algorithm for Children and Crust Display for Parents von Rusu, A., Crowell, A., Petzinger, B., Fabian, A.

Volltext

Cloning and functional characterization of the bile acid–sensitive methotrexate carrier from rat liver cells von Honscha, Walther, Dötsch, Kerstin U., Thomsen, Nadine, Petzinger, Ernst

Volltext

Liver-specific drug targeting by coupling to bile acids von KRAMER, W, WESS, G, MÜLLNER, S, NECKERMANN, G, SCHULZ, S, PETZINGER, E, SCHUBERT, G, BICKEL, M, GIRBIG, F, GUTJAHR, U, KOWALEWSKI, S, BARINGHAUS, K.-H, ENHSEN, A, GLOMBIK, H

Volltext

The peptide-based thrombin inhibitor CRC 220 is a new substrate of the basolateral rat liver organic anion-transporting polypeptide von Eckhardt, U, Horz, JA, Petzinger, E, Stüber, W, Reers, M, Dickneite, G, Daniel, H, Wagener, M, Hagenbuch, B, Stieger, B, Meier, PJ

Volltext

First-pass elimination of a peptidomimetic thrombin inhibitor is due to carrier-mediated uptake by the liver: Interaction with bile acid transport systems von Eckhardt, Uta, Stüber, Werner, Dickneite, Gerhard, Reersf, Martin, Petzinger, Ernst

Volltext

The peptide‐based thrombin inhibitor CRC 220 is a new substrate of the basolateral rat liver organic anion‐transporting polypeptide von Eckhardt, U, Horz, J A, Petzinger, E, Stüber, W, Reers, M, Dickneite, G, Daniel, H, Wagener, M, Hagenbuch, B, Stieger, B, Meier, P J

Volltext

Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE)... von Stumpe, Klaus O, Agabiti-Rosei, Enrico, Zielinski, Tomasz, Schremmer, Dieter, Scholze, Jürgen, Laeis, Petra, Schwandt, Peter, Ludwig, Malte

Volltext

THE ROLE OF THE MDR1 TRANSPORTER IN BODY DISTRIBUTION AND BRAIN PENETRATION OF TROSPIUM CHLORIDE AND OXYBUTYNIN von Petzinger, E, Gavrilova, O, Geyer, J, Schwantes, U

Volltext